<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T03:56:09Z</responseDate>
  <request identifier="oai:figshare.com:article/33948646" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33948646</identifier>
        <datestamp>2026-09-21T04:22:52Z</datestamp>
        <setSpec>category_696</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Identification of SARS-CoV-2-specific cytotoxic lymphocytes in cerebrospinal fluid of a patient with cerebral demyelination Post mRNA vaccination.pdf</dc:title>
          <dc:creator>Takaya Kitano (11040510)</dc:creator>
          <dc:creator>Masakazu Ishikawa (11586838)</dc:creator>
          <dc:creator>Makoto Kinoshita (2566)</dc:creator>
          <dc:creator>Keigo Kihara (14667581)</dc:creator>
          <dc:creator>Shuhei Sakakibara (14667584)</dc:creator>
          <dc:creator>Tomohiro Yata (20655407)</dc:creator>
          <dc:creator>Ryohei Yamamura (20386047)</dc:creator>
          <dc:creator>Hideki Mochizuki (204792)</dc:creator>
          <dc:creator>Masaru Yokoe (504834)</dc:creator>
          <dc:creator>Tatsusada Okuno (339570)</dc:creator>
          <dc:creator>Daisuke Okuzaki (482418)</dc:creator>
          <dc:subject>Genetic Immunology</dc:subject>
          <dc:subject>demyelination</dc:subject>
          <dc:subject>multiple sclerosis</dc:subject>
          <dc:subject>natural killer cells</dc:subject>
          <dc:subject>repertoire</dc:subject>
          <dc:subject>single cell</dc:subject>
          <dc:subject>T cell</dc:subject>
          <dc:subject>vaccination</dc:subject>
          <dc:description>Introduction&lt;p&gt;Some cerebral demyelinating lesions occur after vaccination. We aimed to elucidate the precise roles of vaccine-activated immune cells and antigen-specific lymphocytes in the central nervous system of a patient who developed cerebral demyelination after vaccination.&lt;/p&gt;Methods&lt;p&gt;Using comprehensive single-cell RNA sequencing and immune repertoire analysis combined with a lymphocyte stimulation assay, we characterized the immunological landscape of a patient who developed right-hand clumsiness after receiving an mRNA vaccine against SARS-CoV-2 and was subsequently diagnosed with tumefactive cerebral demyelination.&lt;/p&gt;Results&lt;p&gt;Natural killer cells and effector CD8+ T cells in the cerebrospinal fluid were more cytotoxic and activated than those in healthy controls. Effector CD8+ T cells specific to SARS-CoV-2 spike peptides were identified in the cerebrospinal fluid. The proportion of these cells in peripheral blood decreased after corticosteroid therapy, in parallel with clinical improvement and a reduction in lesion size.&lt;/p&gt;Discussion&lt;p&gt;Although a direct causal relationship between vaccination and demyelination remains uncertain, our findings suggest that vaccine-activated cytotoxic lymphocytes contribute to immune-mediated demyelinating events in the central nervous system.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-21T04:22:52Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fimmu.2026.1920061.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Identification_of_SARS-CoV-2-specific_cytotoxic_lymphocytes_in_cerebrospinal_fluid_of_a_patient_with_cerebral_demyelination_Post_mRNA_vaccination_pdf/33948646</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
